AMLODIPINE-LUPIN amlodipine 10 mg (as besilate) tablet blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

amlodipine besilate, Quantity: 13.868 mg (Equivalent: amlodipine, Qty 10 mg)

Available from:

Lupin Australia Pty Limited

INN (International Name):

amlodipine besilate

Pharmaceutical form:

Tablet, uncoated

Composition:

Excipient Ingredients: microcrystalline cellulose; sodium starch glycollate type A; magnesium stearate; calcium hydrogen phosphate

Administration route:

Oral

Units in package:

30 tablets

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Hypertension: Amlodipine-Lupin tablets are indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. Patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor. Angina: Amlodipine-Lupin tablets are indicated for the first line treatment of chronic stable angina. Amlodipine-Lupin may be used alone, as monotherapy or in combination with other antianginal drugs.

Product summary:

Visual Identification: white to off-white, elongated octagonal, flat-faced, bevelled edge, uncoated tablet debossed with '10' on one side and breakline on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2008-02-15